CLGN
CollPlant Biotechnologies Ltd
$0.34
+0.00 (+0.00%)
At close · Jul 2
Market Cap
$4.91M
Shares
12,803,006
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.34
Open$0.38
Day$0.34–0.38
52W$0.27–3.23
Avg vol 30d69K
Short int21K · 0.2% float · 1.0d
Short vol62%
Last earningsSep 30, 2024
DataJan 2020–Jul 2026
Equibles Rating
blended score · not investment advice
Overall
Buy
Technical · trend & momentum
Sell
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−72% below
−
Price vs 50-day avg
−12% below
◦
RSI (14)
42 · neutral
+
MACD trend
positive
−
52-week position
2% · near low
Sentiment · smart money
Bullish
◦
Trend (MA cross)
50d $0 › 200d $1 — 200d above 50d
+
Institutional flow
+25% holders QoQ · +5 funds added
◦
Insider flow
No net insider activity over 90 days
+
Short interest
0.17% of float · ▼ -50.2% MoM · 1.0 days cover
◦
Volume signal
Volume near normal
+
Institution breadth
20 holders — near 3-yr high, broad support
Fundamentals
Excellent
+
Revenue growth
+360% Y/Y
+
Gross margin
65%, expanding
+
EPS growth
+35% Y/Y
−
Free cash flow
$-9.4M
+
Balance sheet
net cash $5.6M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−72% below
Bearish
Price vs 50-day avg
−12% below
Bearish
RSI (14)
42 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
2% · near low
Bearish
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+25% holders QoQ · +5 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.17% of float · ▼ -50.2% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
20 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $0
Now $0 · 2%
52-wk high $3
vs 200-day avg -72%
vs 50-day avg -12%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CLGN
this stock
CollPlant Biotechnologies Ltd
|
$4.91M | -75.7% | +3565.2% | — | 0.2% |
|
AKTX
Akari Therapeutics Plc
|
$953.21B | -9.9% | — | — | 0.0% |
|
ONC
BeOne Medicines Ltd.
|
$470.30B | -2.0% | +22179.2% | 957.1 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$134.02B | +16.5% | +46.2% | 31.3 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.80B | -15.1% | +20.8% | 16.3 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
20
- % held
- 11.9%
- Net QoQ
- +153.2K sh
- Top holder
- VILLERE ST DENIS J & CO L…
Held
Float
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CLGN | +0.0% | -15.0% | -76.4% | -2.6% | -75.7% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | -1.4% | -13.8% | -84.4% | -2.3% | -84.9% |